Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-04T08:11:02.490Z.
Calculation as of: 2026-10-04T08:11:02.490Z.
Quote observation: 2026-10-02T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 395a61eaa5f3659662bb85ee8347bb0291a2722b08623fc45b62a26fde86276f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$32.21B
Operating Cash Flow Yield
5.43%
TTM Avg
5.47%
3Y Avg
3.44%
5Y Avg
2.59%
Market Cap
$31.12B
Operating Cash Flow Yield
31.39%
TTM Avg
23.69%
3Y Avg
14.48%
5Y Avg
15.21%
Market Cap
$31.10B
Operating Cash Flow Yield
7.32%
TTM Avg
6.05%
3Y Avg
4.82%
5Y Avg
4.29%
Market Cap
$32.49B
Operating Cash Flow Yield
8.86%
TTM Avg
8.98%
3Y Avg
8.47%
5Y Avg
7.79%
Market Cap
$30.11B
Operating Cash Flow Yield
6.62%
TTM Avg
5.16%
3Y Avg
5.16%
5Y Avg
5.16%
Market Cap
$30.03B
Operating Cash Flow Yield
3.25%
TTM Avg
3.52%
3Y Avg
3.63%
5Y Avg
3.31%
Market Cap
$29.40B
Operating Cash Flow Yield
2.16%
TTM Avg
1.28%
3Y Avg
0.83%
5Y Avg
0.83%
Market Cap
$29.22B
Operating Cash Flow Yield
9.88%
TTM Avg
6.70%
3Y Avg
4.52%
5Y Avg
3.71%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ResMed Inc. (RMD) | $31.75B | N/A | N/A | N/A | N/A |
| DexCom, Inc. (DXCM)vs › | $32.21B | 5.43% | 5.47% | 3.44% | 2.59% |
| Centene Corp. (CNC)vs › | $31.12B | 31.39% | 23.69% | 14.48% | 15.21% |
| Alcon Inc. (ALC)vs › | $31.10B | 7.32% | 6.05% | 4.82% | 4.29% |
| Biogen Inc. (BIIB)vs › | $32.49B | 8.86% | 8.98% | 8.47% | 7.79% |
| Medline Inc. (MDLN)vs › | $30.11B | 6.62% | 5.16% | 5.16% | 5.16% |
| Mettler-Toledo International Inc. (MTD)vs › | $30.03B | 3.25% | 3.52% | 3.63% | 3.31% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $29.40B | 2.16% | 1.28% | 0.83% | 0.83% |
| Zoetis Inc. (ZTS)vs › | $29.22B | 9.88% | 6.70% | 4.52% | 3.71% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $29.04B | 4.88% | 5.67% | 5.62% | 5.60% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
